UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Chest, 2012-08, Vol.142 (2), p.448-456

2012

Volltextzugriff (PDF)

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

Chest, 2012-02, Vol.141 (2), p.354-362

2012

Volltextzugriff (PDF)

World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

The Journal of heart and lung transplantation, 2012-09, Vol.31 (9), p.913-933

2012

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension: Epidemiology and Registries

Journal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D51-D59

2013

Volltextzugriff (PDF)

Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)

Circulation (New York, N.Y.), 2010-07, Vol.122 (2), p.164-172

2010

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry

Chest, 2010-02, Vol.137 (2), p.376-387

2010

Volltextzugriff (PDF)

Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension: A Randomized Controlled Clinical Trial

Journal of the American College of Cardiology, 2010-05, Vol.55 (18), p.1915-1922

2010

Volltextzugriff (PDF)

The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States: How REVEAL Differs From Historic and Non-US Contemporary Registries

Chest, 2011, Vol.139 (1), p.128-137

2011

Volltextzugriff (PDF)

Clinical risk factors for portopulmonary hypertension

Hepatology (Baltimore, Md.), 2008-07, Vol.48 (1), p.196-203

2008

Volltextzugriff (PDF)

Role of Cardiac Magnetic Resonance Imaging in the Management of Patients With Pulmonary Arterial Hypertension

Journal of the American College of Cardiology, 2008-11, Vol.52 (21), p.1683-1692

2008

Volltextzugriff (PDF)

Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials

The Journal of heart and lung transplantation, 2011-09, Vol.30 (9), p.982-989

2011

Volltextzugriff (PDF)

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension

The Journal of heart and lung transplantation, 2011-12, Vol.30 (12), p.1327-1333

2011

Volltextzugriff (PDF)

Compelling Evidence of Long-Term Outcomes in Pulmonary Arterial Hypertension?: A Clinical Perspective

Journal of the American College of Cardiology, 2011-03, Vol.57 (9), p.1053-1061

2011

Volltextzugriff (PDF)

Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary Hypertension

American journal of respiratory and critical care medicine, 2005-12, Vol.172 (12), p.1586-1589

2005

Volltextzugriff (PDF)

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension : A prospective, multicenter, open-label, 12-week trial

Chest, 2006-03, Vol.129 (3), p.683-688

2006

Volltextzugriff (PDF)

Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease

American journal of respiratory and critical care medicine, 2009-05, Vol.179 (9), p.835-842

2009

Volltextzugriff (PDF)

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2004-04, Vol.291 (16), p.1963

2004

Volltextzugriff (PDF)

The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis

Circulation (New York, N.Y.), 2003-03, Vol.107 (10), p.1359-1365

2003

Volltextzugriff (PDF)

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies

British journal of haematology, 2010-05, Vol.149 (3), p.426-435

2010

Volltextzugriff (PDF)

Heart Failure Etiology and response to Milrinone in decompensated heart failure: Results from the OPTIME-CHF study

Journal of the American College of Cardiology, 2003-03, Vol.41 (6), p.997-1003

2003

Volltextzugriff (PDF)

The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists

Transplantation, 2012-11, Vol.94 (9), p.885-893

2012

Volltextzugriff (PDF)

Sitaxsentan for the Treatment of Pulmonary Arterial Hypertension : A 1-Year, Prospective, Open-Label Observation of Outcome and Survival

Chest, 2008-10, Vol.134 (4), p.775-782

2008

Volltextzugriff (PDF)

Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study

Journal of the American College of Cardiology, 2002-09, Vol.40 (5), p.970-975

2002

Volltextzugriff (PDF)

Management of Pulmonary Arterial Hypertension With a Focus on Combination Therapies

The Journal of heart and lung transplantation, 2007-05, Vol.26 (5), p.437-446

2007

Volltextzugriff (PDF)

Prevention of Acute Rejection and Allograft Vasculopathy by Everolimus in Cardiac Transplants Recipients: A 24-Month Analysis

The Journal of heart and lung transplantation, 2007-06, Vol.26 (6), p.584-592

2007

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(68)
Tagungsberichte
(1)

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

Medical Sciences
(69)
Humans
(62)
Life Sciences & Biomedicine
(62)
Science & Technology
(62)
Male
(42)
Female
(40)
Middle Aged
(40)
Cardiovascular System & Cardiology
(37)
Cardiology. Vascular System
(36)
Cardiac & Cardiovascular Systems
(33)
Respiratory System
(33)
Adult
(32)
Pneumology
(30)
Pulmonary Hypertension. Acute Cor Pulmonale. Pulmonary Embolism. Pulmonary Vascular Diseases
(30)
Aged
(21)
Surgery
(21)
Transplantation
(19)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(18)
Hypertension, Pulmonary - Drug Therapy
(17)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

Pulmonary Arterial Hypertension: Epidemiology and Registries

Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)

Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry

Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension: A Randomized Controlled Clinical Trial

The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States: How REVEAL Differs From Historic and Non-US Contemporary Registries

Clinical risk factors for portopulmonary hypertension

Role of Cardiac Magnetic Resonance Imaging in the Management of Patients With Pulmonary Arterial Hypertension

Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension

Compelling Evidence of Long-Term Outcomes in Pulmonary Arterial Hypertension?: A Clinical Perspective

Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary Hypertension

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension : A prospective, multicenter, open-label, 12-week trial

Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies

Heart Failure Etiology and response to Milrinone in decompensated heart failure: Results from the OPTIME-CHF study

The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists

Sitaxsentan for the Treatment of Pulmonary Arterial Hypertension : A 1-Year, Prospective, Open-Label Observation of Outcome and Survival

Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study

Management of Pulmonary Arterial Hypertension With a Focus on Combination Therapies

Prevention of Acute Rejection and Allograft Vasculopathy by Everolimus in Cardiac Transplants Recipients: A 24-Month Analysis

Aktive Filter

Suchergebnisse filtern